Photodynamic therapy of early-stage lung cancer.

H. Kato, Norihiko Kawate, K. Kinoshita, H. Yamamoto, K. Furukawa, Y. Hayata

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The clinical efficacy of photodynamic therapy (PDT) was evaluated in cases of early-stage lung cancer. Haematoporphyrin derivative was used as a photosensitizer and an argon dye laser and excimer dye laser were used as the light sources. A total of 199 lesions in 165 patients with lung cancer were treated by PDT. Forty-five lesions in 40 patients, which had been detected only by sputum cytology, were endoscopically suggestive of early-stage lung cancer. All patients showed normal chest X-ray findings. Thirty lesions in 26 patients were treated by PDT only, with or without other conservative treatment because of poor pulmonary function or for other reasons. All lesions initially showed complete remission. Recurrences were seen in three cases. Nine patients died of unrelated causes and one patient died after a recurrence. The other 16 patients are alive and apparently free of the disease. Fifteen lesions were treated surgically after PDT because the effectiveness of PDT was uncertain. Among these, five lesions showed complete remission histologically. Three of the PDT-only patients have now survived for more than five years. The longest surviving patient has gone eight years without apparent recurrence.

Original languageEnglish
Pages (from-to)183-194
Number of pages12
JournalCiba Foundation symposium
Volume146
Publication statusPublished - 1989
Externally publishedYes

Fingerprint

Photochemotherapy
Lung Neoplasms
Dye Lasers
Recurrence
Hematoporphyrin Derivative
Excimer Lasers
Photosensitizing Agents
Argon
Sputum
Cell Biology
Thorax
X-Rays
Light
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kato, H., Kawate, N., Kinoshita, K., Yamamoto, H., Furukawa, K., & Hayata, Y. (1989). Photodynamic therapy of early-stage lung cancer. Ciba Foundation symposium, 146, 183-194.

Photodynamic therapy of early-stage lung cancer. / Kato, H.; Kawate, Norihiko; Kinoshita, K.; Yamamoto, H.; Furukawa, K.; Hayata, Y.

In: Ciba Foundation symposium, Vol. 146, 1989, p. 183-194.

Research output: Contribution to journalArticle

Kato, H, Kawate, N, Kinoshita, K, Yamamoto, H, Furukawa, K & Hayata, Y 1989, 'Photodynamic therapy of early-stage lung cancer.', Ciba Foundation symposium, vol. 146, pp. 183-194.
Kato H, Kawate N, Kinoshita K, Yamamoto H, Furukawa K, Hayata Y. Photodynamic therapy of early-stage lung cancer. Ciba Foundation symposium. 1989;146:183-194.
Kato, H. ; Kawate, Norihiko ; Kinoshita, K. ; Yamamoto, H. ; Furukawa, K. ; Hayata, Y. / Photodynamic therapy of early-stage lung cancer. In: Ciba Foundation symposium. 1989 ; Vol. 146. pp. 183-194.
@article{f30d52361f4f477dbab1971bd2af1d38,
title = "Photodynamic therapy of early-stage lung cancer.",
abstract = "The clinical efficacy of photodynamic therapy (PDT) was evaluated in cases of early-stage lung cancer. Haematoporphyrin derivative was used as a photosensitizer and an argon dye laser and excimer dye laser were used as the light sources. A total of 199 lesions in 165 patients with lung cancer were treated by PDT. Forty-five lesions in 40 patients, which had been detected only by sputum cytology, were endoscopically suggestive of early-stage lung cancer. All patients showed normal chest X-ray findings. Thirty lesions in 26 patients were treated by PDT only, with or without other conservative treatment because of poor pulmonary function or for other reasons. All lesions initially showed complete remission. Recurrences were seen in three cases. Nine patients died of unrelated causes and one patient died after a recurrence. The other 16 patients are alive and apparently free of the disease. Fifteen lesions were treated surgically after PDT because the effectiveness of PDT was uncertain. Among these, five lesions showed complete remission histologically. Three of the PDT-only patients have now survived for more than five years. The longest surviving patient has gone eight years without apparent recurrence.",
author = "H. Kato and Norihiko Kawate and K. Kinoshita and H. Yamamoto and K. Furukawa and Y. Hayata",
year = "1989",
language = "English",
volume = "146",
pages = "183--194",
journal = "Ciba Foundation symposium",
issn = "0300-5208",
publisher = "Wiley Subscription Services",

}

TY - JOUR

T1 - Photodynamic therapy of early-stage lung cancer.

AU - Kato, H.

AU - Kawate, Norihiko

AU - Kinoshita, K.

AU - Yamamoto, H.

AU - Furukawa, K.

AU - Hayata, Y.

PY - 1989

Y1 - 1989

N2 - The clinical efficacy of photodynamic therapy (PDT) was evaluated in cases of early-stage lung cancer. Haematoporphyrin derivative was used as a photosensitizer and an argon dye laser and excimer dye laser were used as the light sources. A total of 199 lesions in 165 patients with lung cancer were treated by PDT. Forty-five lesions in 40 patients, which had been detected only by sputum cytology, were endoscopically suggestive of early-stage lung cancer. All patients showed normal chest X-ray findings. Thirty lesions in 26 patients were treated by PDT only, with or without other conservative treatment because of poor pulmonary function or for other reasons. All lesions initially showed complete remission. Recurrences were seen in three cases. Nine patients died of unrelated causes and one patient died after a recurrence. The other 16 patients are alive and apparently free of the disease. Fifteen lesions were treated surgically after PDT because the effectiveness of PDT was uncertain. Among these, five lesions showed complete remission histologically. Three of the PDT-only patients have now survived for more than five years. The longest surviving patient has gone eight years without apparent recurrence.

AB - The clinical efficacy of photodynamic therapy (PDT) was evaluated in cases of early-stage lung cancer. Haematoporphyrin derivative was used as a photosensitizer and an argon dye laser and excimer dye laser were used as the light sources. A total of 199 lesions in 165 patients with lung cancer were treated by PDT. Forty-five lesions in 40 patients, which had been detected only by sputum cytology, were endoscopically suggestive of early-stage lung cancer. All patients showed normal chest X-ray findings. Thirty lesions in 26 patients were treated by PDT only, with or without other conservative treatment because of poor pulmonary function or for other reasons. All lesions initially showed complete remission. Recurrences were seen in three cases. Nine patients died of unrelated causes and one patient died after a recurrence. The other 16 patients are alive and apparently free of the disease. Fifteen lesions were treated surgically after PDT because the effectiveness of PDT was uncertain. Among these, five lesions showed complete remission histologically. Three of the PDT-only patients have now survived for more than five years. The longest surviving patient has gone eight years without apparent recurrence.

UR - http://www.scopus.com/inward/record.url?scp=0024824975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024824975&partnerID=8YFLogxK

M3 - Article

VL - 146

SP - 183

EP - 194

JO - Ciba Foundation symposium

JF - Ciba Foundation symposium

SN - 0300-5208

ER -